Literature DB >> 823140

Total body irradiation as treatment for lymphosarcoma.

J T Chaffey, D S Rosenthal, W C Moloney, S Hellman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 823140     DOI： 10.1016/0360-3016(76)90004-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  13 in total

1.  Nuclear energy and health: and the benefits of low-dose radiation hormesis.

Authors:  Jerry M Cuttler; Myron Pollycove
Journal:  Dose Response       Date:  2008-11-10       Impact factor: 2.658

2.  Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases.

Authors:  Bobby R Scott; Jennifer Di Palma
Journal:  Dose Response       Date:  2006-12-21       Impact factor: 2.658

3.  [Total body irradiation plus combination chemotherapy in patients with low-grade malignant non-Hodgkin's lymphoma (author's transl)].

Authors:  S Ohl; M Bamberg; H Holfeld; K Höffken; C G Schmidt; E Scherer
Journal:  Blut       Date:  1979-02-19

4.  Radiobiological basis of low-dose irradiation in prevention and therapy of cancer.

Authors:  Myron Pollycove
Journal:  Dose Response       Date:  2006-11-27       Impact factor: 2.658

5.  Radiobiological basis for cancer therapy by total or half-body irradiation.

Authors:  Kiyohiko Sakamoto
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-10

6.  Changing the Paradigm of Cancer Screening, Prevention, and Treatment.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2016-11-30       Impact factor: 2.658

Review 7.  Cancer immunotherapy: how low-level ionizing radiation can play a key role.

Authors:  Marek K Janiak; Marta Wincenciak; Aneta Cheda; Ewa M Nowosielska; Edward J Calabrese
Journal:  Cancer Immunol Immunother       Date:  2017-03-30       Impact factor: 6.968

Review 8.  Health Impacts of Low-Dose Ionizing Radiation: Current Scientific Debates and Regulatory Issues.

Authors:  Alexander Vaiserman; Alexander Koliada; Oksana Zabuga; Yehoshua Socol
Journal:  Dose Response       Date:  2018-09-19       Impact factor: 2.658

9.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

Review 10.  Mutation and cancer in relation to the atomic-bomb radiation effects.

Authors:  S Kondo
Journal:  Jpn J Cancer Res       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.